Biological Medications / Plasma / Insulin
OVERVIEW
Full Tech Transfer and localization of Bio-Pharmaceutical medications.
Opportunity Highlights
- Expected Investment size of USD (1.8 Billion for the whole segment and not capex / plant ( - capex/ plant is 375 Million)
- Plant capacity: Subjected to review ktpa
- Expected IRR: -Subjected to review %
- Payback period: Subjected to review years
- Job Creation: 330 till 2035 (Source NIS)
- GDP Impact: Subjected to review %
contact our Biological Medications / Plasma / Insulin Expert
Thank you for your interest in the Invest Saudi.
We received your inquiry, and we will get back to you shortly.
